Jamp-Senna 8.6 mg tablet; Out of Specification (Total yeast & mold count; total aerobic microbiological count)
Brand(s)
Last updated
Summary
Product
Jamp-Senna 8.6 mg table
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Jamp Pharma | Jamp-Senna 8.6 mg tablet | NPN 80009595 | Tablet | Sennoside A&B 8.6 mg | 2A02B3016 |
Issue
The total yeast and mold count (TYMC) and total aerobic microbiological count (TAMC) are out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
JAMP PHARMA CORPORATION
1310 rue Nobel,
Boucherville, QC, J4B 5H3 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Recall date
Identification number
RA-78114
Get notified
Receive emails about new and updated recall and safety alerts.